New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists
Authors:
- Daniel PagéDPDaniel Pagé
- Hua YangHYHua Yang
- William BrownWBWilliam Brown
- Christopher WalpoleCWChristopher Walpole
- Manon FleurentMFManon Fleurent
- Meredith FyfeMFMeredith Fyfe
- François GaudreaultFGFrançois Gaudreault
- Stéphane St-OngeSSStéphane St-Onge
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (22) , 6183-6187
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical ApproachesMini-Reviews in Medicinal Chemistry, 2007
- Endocannabinoid mechanisms of pain modulationThe AAPS Journal, 2006
- Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking CessationCurrent Medicinal Chemistry, 2006
- Antiobesity Therapy: Emerging Drugs and TargetsCurrent Medicinal Chemistry, 2006
- CANNABINOID RECEPTORS AS THERAPEUTIC TARGETSAnnual Review of Pharmacology and Toxicology, 2006
- The Endocannabinoid System: Current Pharmacological Research and Therapeutic PossibilitiesBasic & Clinical Pharmacology & Toxicology, 2006
- Cannabinoids and CancerMini-Reviews in Medicinal Chemistry, 2005
- [General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNSCurrent Medicinal Chemistry, 2003
- Cannabinoids and Neuropathic PainMini-Reviews in Medicinal Chemistry, 2003
- Cannabinoids modulate pain by multiple mechanisms of actionThe Journal of Pain, 2000